| Due Diligence for Asset Managers |
|---|
|
Analyze the public filings of asset managers Dive into the EDGAR, IAPD, CAFR source data |
|
⚲
|
| Keyboard |
| Beam Therapeutics Inc | |
|---|---|
| Ticker | BEAM |
| CIK # | 0001745999 |
| CUSIP | 073730103 |
| Sector | Life Sciences - Biological Products, (No Disgnostic Substances) |
| Address | 26 Landsdowne Street, Cambridge, MA 02139 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Beam Therapeutics Inc | 2019-03-26 | 135.0 M | Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001745999] | 10-K | |
| [0001745999] | 10-Q | |
| [0001745999] | 3 | |
| [0001745999] | 4 | |
| [0001745999] | 8-K | |
| [0001745999] | D | |
| [0001745999] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Ciaramella Giuseppe
Common Stock
|
2026-02-24 | Sell | 35,000 | $32.00 | 1,120,000 |
|
Ciaramella Giuseppe
Stock Option (Right to Buy) · derivative
|
2026-02-24 | Option exercise | 35,000 | $0.00 | |
|
Ciaramella Giuseppe
Common Stock
|
2026-02-24 | Option exercise | 35,000 | $17.00 | 595,000 |
|
Evans John M
Stock Option (Right to Buy) · derivative
|
2026-01-31 | Grant | 180,000 | $0.00 | |
|
Cavanagh Bethany J
Stock Option (Right to Buy) · derivative
|
2026-01-31 | Grant | 40,000 | $0.00 | |
|
Bellon Christine
Stock Option (Right to Buy) · derivative
|
2026-01-31 | Grant | 40,000 | $0.00 | |
|
Ciaramella Giuseppe
Stock Option (Right to Buy) · derivative
|
2026-01-31 | Grant | 80,000 | $0.00 | |
|
Emany Sravan Kumar
Stock Option (Right to Buy) · derivative
|
2026-01-31 | Grant | 63,500 | $0.00 | |
|
Simon Amy
Stock Option (Right to Buy) · derivative
|
2026-01-31 | Grant | 88,500 | $0.00 | |
|
Evans John M
Common Stock
|
2026-01-30 | Sell | 2,906 | $29.00 | 84,274 |
|
Evans John M
Common Stock
|
2026-01-30 | Sell | 22,094 | $28.27 | 624,597 |
|
Evans John M
Common Stock
|
2026-01-30 | Option exercise | 25,000 | $0.67 | 16,750 |
|
Evans John M
Stock Option (Right to Buy) · derivative
|
2026-01-30 | Option exercise | 25,000 | $0.00 | |
|
Evans John M
Common Stock
|
2026-01-29 | Sell | 8,667 | $29.74 | 257,757 |
|
Evans John M
Common Stock
|
2026-01-29 | Option exercise | 5,664 | $0.67 | 3,795 |
|
Evans John M
Common Stock
|
2026-01-29 | Sell | 16,333 | $29.19 | 476,760 |
|
Evans John M
Common Stock
|
2026-01-29 | Option exercise | 19,336 | $0.67 | 12,955 |
|
Evans John M
Stock Option (Right to Buy) · derivative
|
2026-01-29 | Option exercise | 5,664 | $0.00 | |
|
Evans John M
Stock Option (Right to Buy) · derivative
|
2026-01-29 | Option exercise | 19,336 | $0.00 | |
|
Cavanagh Bethany J
Common Stock
|
2026-01-22 | Sell | 6,198 | $35.00 | 216,930 |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 256 | 106,179,548 |
| 2025-12-31 | 249 | 106,713,889 |
| 2025-09-30 | 227 | 106,278,379 |
| 2025-06-30 | 219 | 109,255,814 |
| 2025-03-31 | 240 | 99,192,200 |
| 2024-12-31 | 238 | 80,155,642 |
| 2024-09-30 | 224 | 78,884,972 |
| 2024-06-30 | 218 | 77,427,258 |
| 2024-03-31 | 228 | 78,841,988 |
| 2023-12-31 | 192 | 74,106,220 |
| 2023-09-30 | 200 | 68,103,110 |
| 2023-06-30 | 199 | 64,713,383 |